NextGeM
NextGeM develops the next generative medicine using tissue stem cells.
Operating in biotechnology, health care, life science based in Asia-Pacific (APAC), NextGeM was founded in 2016.
The company sits in the biotechnology, health care, life science segment, where it competes on its core product or service.
The business is associated with Asia-Pacific (APAC).
Its current recorded stage is Seed.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $1.8M.
| Sector | Biotechnology, Health Care, Life Science |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Country | NL |
| Founded | 2016 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $1,800,000 |
Website: nextgem.jp
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account